Table 2 Classification, site of infection and complications of Candida bloodstream infection
|  | Total N = 77 | C. albicans BSI N = 38 | Non-C. albicans BSI N = 39 | P value* |
|---|---|---|---|---|
Classification of Candida bloodstream infection | ||||
 Infection present on admission | 14 (18) | 6 (16) | 8 (21) | 0.8 |
 Healthcare-associated infection | 63 (82) | 32 (84) | 31 (80) | 0.8 |
Site of infection | ||||
 No definable focus of infection | 43 (56) | 17 (45) | 26 (66) | 0.07 |
 Urinary tract | 15 (20) | 14 (37) | 1 (3) |  < 0.001 |
 Intravenous/arterial catheter | 17 (22) | 5 (13) | 12 (31) | 0.1 |
 Abdomen | 2 (3) | 2 (5) | 0 (0) | 0.2 |
Complications | ||||
 Disseminated intravascular coagulopathy | 9 (12) | 3 (8) | 6 (15) | 0.5 |
 Vasopressor therapy requirement | 22 (29) | 15 (40) | 7 (18) | 0.05 |
 Renal dysfunction | 15 (20) | 14 (37) | 1 (3) |  < 0.001 |
 Confusion | 35 (46) | 20 (53) | 15 (39) | 0.3 |
 Liver dysfunction | 15 (20) | 7 (18) | 8 (21) | 1.0 |
Co-infection | ||||
 Concomitant bacterial BSI | 23 (30) | 12 (32) | 11 (28) | 0.8 |